# OnCo record vinblastine (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/vinblastine/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "vinblastine" ;
  schema:name "Vinblastine"@en ;
  schema:description "Vinblastine is the vinca alkaloid in ABVD, the standard Hodgkin lymphoma regimen, and was formerly in the cisplatin combinations that first cured testicular cancer."@en ;
  schema:url <https://onco.cc/drugs/vinblastine/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Vinblastine> ;
  owl:sameAs <http://www.wikidata.org/entity/Q282629> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=vinblastine> ;
  onco:status "approved" ;
  onco:tag "gap-fill", "generic", "who-essential" ;
  onco:modality "Vinca alkaloid (microtubule inhibitor)" ;
  schema:alternateName "Velban" ;
  onco:approval "US 1965: Hodgkin lymphoma, testicular cancer, Kaposi sarcoma, choriocarcinoma, breast cancer and others" ;
  onco:cancers <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/testicular/>, <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/kaposi-sarcoma/>, <https://onco.cc/cancers/lch-single-system/>, <https://onco.cc/cancers/lch-multisystem/>, <https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:companies <https://onco.cc/companies/eli-lilly/> ;
  onco:trials <https://onco.cc/trials/nct03407144/>, <https://onco.cc/trials/nct02979522/>, <https://onco.cc/trials/nct06960577/> .